Literature DB >> 11284659

Human reproductive failure II: immunogenetic and interacting factors.

S R Choudhury1, L A Knapp.   

Abstract

Studies in humans suggest that reproductive failure may be influenced by immunological factors or by genes encoding immunological factors and regulatory mechanisms controlling immunological expression. Using molecular methods, immunological factors can be clearly studied in an immunogenetic context. One example, the major histocompatibility complex (MHC), known as the human leukocyte antigens (HLA) in humans and MHC in other mammals, affects many different stages of reproduction. Studies in some outbred, and in closely related, human populations indicate that HLA, or HLA-linked, genes and HLA regulatory factors affect gamete development, embryo cleavage, blastocyst and trophoblast formation, implantation, fetal development and survival. Studies in non-human mammals indicate that MHC, or MHC-linked, genes such as the grc complex, Ped/Qa-2, t haplotypes and MHC regulatory factors, have similar reproductive effects. Human reproductive failure may also be a consequence of disruption of interacting factors, including interactions between HLA antigens, cytokines and natural killer (NK) cells. In this review, we highlight the importance of immunogenetic and interacting factors in human reproductive failure. We argue that studies in closely related human populations and animal models may contribute to a better understanding of the ways in which immunogenetic and interacting factors are involved in human reproduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284659     DOI: 10.1093/humupd/7.2.135

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  8 in total

1.  HLA and genomewide allele sharing in dizygotic twins.

Authors:  Grant W Montgomery; Gu Zhu; Jouke Jan Hottenga; David L Duffy; Andrew C Heath; Dorret I Boomsma; Nicholas G Martin; Peter M Visscher
Journal:  Am J Hum Genet       Date:  2006-10-23       Impact factor: 11.025

2.  Deleterious impact of feto-maternal MHC compatibility on the success of pregnancy in a macaque model.

Authors:  Alice Aarnink; Edward T Mee; Nicolas Savy; Nicolas Congy-Jolivet; Nicola J Rose; Antoine Blancher
Journal:  Immunogenetics       Date:  2013-12-28       Impact factor: 2.846

3.  The live birth and neonatal outcomes in the subsequent pregnancy among patients with adverse pregnancy outcomes in first frozen embryo transfer cycles.

Authors:  Jianghui Li; Jiaying Lin; Mingru Yin; Qianqian Zhu; Yanping Kuang
Journal:  Arch Gynecol Obstet       Date:  2020-05-28       Impact factor: 2.344

4.  Maternal-Fetal HLA Compatibility in Uncomplicated and Preeclamptic Naturally Conceived Pregnancies.

Authors:  Liseanne J van 't Hof; Naomi Schotvanger; Geert W Haasnoot; Carin van der Keur; Dave L Roelen; Lisa E E L O Lashley; Frans H J Claas; Michael Eikmans; Marie-Louise P van der Hoorn
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 5.  Immunogenetic contributions to recurrent pregnancy loss.

Authors:  Frances Grimstad; Sacha Krieg
Journal:  J Assist Reprod Genet       Date:  2016-05-12       Impact factor: 3.357

6.  Increase in concentration of soluble HLA-G in high-quality embryos after intracytoplasmic sperm injection.

Authors:  Mohammad Hassan Heidari; Marefat Ghaffari Novin; Farzaneh Ahmadi; Mehran Khorshid; Tohid Najafi; Aidin Molouki; Saghar Salehpour; Mojgan Bandehpour; Matineh Heidari; Eimi Sato
Journal:  Anat Cell Biol       Date:  2011-12-30

Review 7.  Testing the theory of immune selection in cancers that break the rules of transplantation.

Authors:  Ariberto Fassati; N Avrion Mitchison
Journal:  Cancer Immunol Immunother       Date:  2009-12-22       Impact factor: 6.968

8.  Impact of Thyroid Autoimmunity in euthyroid women on the outcomes of In Vitro Fertilization.

Authors:  Ahed Hamad; Nawras Alhalabi; Nazht Nmr; Fatima Abbas; Hisham Al-Hammami; Nazir Ibrahim; Marwan Alhalabi
Journal:  Ann Med Surg (Lond)       Date:  2021-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.